Teladoc Health, Inc. - Laporan Laba Rugi (TTM)

Teladoc Health, Inc.
US ˙ NYSE ˙ US87918A1051

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Teladoc Health, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 867 1,094 1,367 1,629 1,862 2,033 2,144 2,234 2,323 2,407 2,471 2,531 2,580 2,602 2,619 2,609 2,590 2,570 2,553 2,542
Change (%) 26.16 24.94 19.18 14.29 9.18 5.49 4.16 4.02 3.59 2.65 2.43 1.93 0.88 0.65 -0.38 -0.76 -0.77 -0.65 -0.41
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 323 391 464 534 598 650 691 714 730 744 747 755 755 760 764 762 756 751 754 756
Change (%) 20.91 18.83 14.96 12.05 8.70 6.32 3.21 2.32 1.90 0.41 1.08 0.05 0.60 0.58 -0.32 -0.82 -0.59 0.30 0.33
% of Revenue 37.28 35.73 33.98 32.78 32.13 31.99 32.24 31.94 31.42 30.91 30.24 29.84 29.29 29.20 29.19 29.20 29.18 29.24 29.52 29.74
Gross Operating Profit 544 703 902 1,095 1,264 1,382 1,453 1,520 1,593 1,663 1,724 1,776 1,824 1,842 1,855 1,847 1,834 1,818 1,799 1,786
Change (%) 29.28 28.34 21.34 15.39 9.41 5.11 4.61 4.81 4.37 3.66 3.01 2.73 1.00 0.68 -0.40 -0.73 -0.85 -1.05 -0.72
% of Revenue 62.72 64.27 66.02 67.22 67.87 68.01 67.76 68.06 68.58 69.09 69.76 70.16 70.71 70.80 70.81 70.80 70.82 70.76 70.48 70.26
SG&A 443 887 1,049 1,205 1,346 1,105 1,143 1,200 1,269 1,301 1,349 1,372 1,380 1,367 1,371 1,343 1,328 1,346 1,327 1,322
Change (%) 100.06 18.33 14.81 11.72 -17.89 3.39 5.01 5.75 2.49 3.73 1.68 0.62 -0.94 0.29 -2.03 -1.12 1.35 -1.47 -0.35
% of Revenue 51.12 81.07 76.78 73.97 72.30 54.38 53.29 53.72 54.62 54.04 54.60 54.20 53.51 52.54 52.35 51.48 51.30 52.39 51.96 52.00
R&D 88 165 224 281 332 312 321 319 324 334 333 342 342 349 343 332 320 307 296 288
Change (%) 86.40 35.62 25.81 17.87 -5.98 3.02 -0.64 1.36 3.11 -0.13 2.58 -0.09 2.05 -1.61 -3.08 -3.58 -4.11 -3.72 -2.69
% of Revenue 10.20 15.08 16.37 17.28 17.82 15.34 14.98 14.29 13.93 13.86 13.49 13.51 13.24 13.39 13.09 12.74 12.37 11.96 11.59 11.32
OpEx 897 1,512 1,846 2,170 2,465 2,272 2,370 2,455 2,555 2,624 2,696 2,752 2,793 2,813 2,844 2,824 2,786 2,778 2,739 2,726
Change (%) 68.49 22.08 17.56 13.58 -7.84 4.32 3.60 4.07 2.70 2.74 2.05 1.49 0.73 1.10 -0.70 -1.34 -0.28 -1.40 -0.50
% of Revenue 103.50 138.23 135.06 133.22 132.39 111.76 110.52 109.92 109.98 109.04 109.13 108.73 108.26 108.09 108.57 108.23 107.59 108.13 107.31 107.22
Operating Income -30 -418 -479 -541 -603 -239 -226 -222 -232 -217 -226 -221 -213 -211 -225 -215 -197 -209 -187 -183
Change (%) 1,278.33 14.59 12.93 11.44 -60.37 -5.64 -1.71 4.61 -6.21 3.72 -2.05 -3.61 -1.15 6.66 -4.38 -8.44 6.23 -10.60 -1.69
% of Revenue -3.50 -38.23 -35.06 -33.22 -32.39 -11.76 -10.52 -9.92 -9.98 -9.04 -9.13 -8.73 -8.26 -8.09 -8.57 -8.23 -7.59 -8.13 -7.31 -7.22
Interest Expense -50 -60 -74 -81 -83 -81 -63 -49 -36 -22 -22 -22 -21 -22 -23 -22 -22 -24 -24 -23
Change (%) 19.44 23.06 9.57 2.18 -1.76 -21.80 -22.82 -26.03 -39.43 0.46 -0.94 -2.30 4.45 1.73 -0.82 0.06 5.81 0.49 -4.91
% of Revenue -5.79 -5.48 -5.40 -4.96 -4.44 -3.99 -2.96 -2.19 -1.56 -0.91 -0.89 -0.86 -0.83 -0.86 -0.87 -0.86 -0.87 -0.93 -0.94 -0.89
Net Income -110 -485 -655 -763 -812 -429 -6,904 -9,871 -9,860 -13,660 -7,054 -4,018 -4,002 -220 -233 -1,006 -982 -1,001 -1,012 -207
Change (%) 340.18 35.05 16.50 6.35 -47.18 1,510.02 42.99 -0.11 38.53 -48.36 -43.04 -0.41 -94.49 5.75 331.50 -2.37 1.99 1.11 -79.52
% of Revenue -12.71 -44.35 -47.93 -46.86 -43.60 -21.09 -321.94 -441.94 -424.40 -567.53 -285.51 -158.76 -155.12 -8.47 -8.90 -38.54 -37.91 -38.97 -39.66 -8.16

Source: Capital IQ

Other Listings
MX:TDOC
GB:0LDR
DE:4LL € 6.59
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista